Evidence map›Paper›PMID 31783709›Full record

ArticleMarine drugs2019

Sinulariolide Inhibits Gastric Cancer Cell Migration and Invasion through Downregulation of the EMT Process and Suppression of FAK/PI3K/AKT/mTOR and MAPKs Signaling Pathways.

Yu-Jen Wu, Shih-Hsiung Lin, Zhong-Hao Din, Jui-Hsin Su, Chih-I Liu

Open access · goldAbstract read
In one paragraph

Article in Marine drugs, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 54 citations in OpenAlex.

  1. Review
  2. Article
  3. Analysis of Cembrane-Type Diterpenoids from Cultured Soft CoralInternational journal of molecular sciences · 2025
    Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Targeting PI3K/AKT/mTOR and MAPK Signaling Pathways in Gastric Cancer.International journal of molecular sciences · 2024
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Yu-Jen WuDepartment of Nursing, Meiho University, Pingtung 91202, Taiwan.
Shih-Hsiung LinDepartment of Pediatrics, Antai Medical Care Corporation Antai Tian-Sheng Memorial Hospital, Pingtung 92842, Taiwan.
Zhong-Hao DinYu Jun Biotechnology Co., Ltd., Kaoshiung 807, Taiwan.
Jui-Hsin SuNational Museum of Marine Biology and Aquarium, Pingtung 94450, Taiwan.
Chih-I LiuDepartment of Nursing, Meiho University, Pingtung 91202, Taiwan.
Yu Jun BiotechnologyMeiho University · TWNational Museum of Marine Biology and Aquarium · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer metastasis is the main cause of death in cancer patients; however, there is currently no effective method to predict and prevent metastasis of gastric cancer. Therefore, gaining an understanding of the molecular mechanism of tumor metastasis is important for the development of new drugs and improving the survival rate of patients who suffer from gastric cancer. Sinulariolide is an active compound isolated from the cultured soft coral

Indexed as

AnimalsCell MovementDiterpenesDown-RegulationFocal Adhesion Kinase 1HumansMAP Kinase Signaling SystemNeoplasm MetastasisPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktSignal TransductionStomach NeoplasmsTissue Inhibitor of Metalloproteinase-2TOR Serine-Threonine KinasesAKT1 protein, humanDiterpenesFocal Adhesion Kinase 1MTOR protein, humanPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktPTK2 protein, humansinulariolideTIMP2 protein, humanTissue Inhibitor of Metalloproteinase-2TOR Serine-Threonine Kinasescell invasioncell migrationgastric cancer cellssinulariolidesoft coral

Identifiers

PMID31783709
PMCPMC6950622
OpenAlexW2989950892

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.